Log in to save to my catalogue

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7334273

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients

About this item

Full title

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients

Publisher

New York: Springer US

Journal title

Cardiovascular drugs and therapy, 2020-08, Vol.34 (4), p.555-568

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Ischaemic stroke and systemic embolism are the major potentially preventable complications of atrial fibrillation (AF) leading to severe morbidity and mortality. Anticoagulation using vitamin K antagonists (VKA) or non-vitamin K oral anticoagulants (NOACs) is mandatory for stroke prevention in AF. Following approval of the four NOACs dabigatran, ri...

Alternative Titles

Full title

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7334273

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7334273

Other Identifiers

ISSN

0920-3206,1573-7241

E-ISSN

1573-7241

DOI

10.1007/s10557-020-06981-3

How to access this item